4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Gao, J; Jia, Y; Jiang, R; Lai, F; Liu, X; Tang, Y; Xiao, H; Xie, W | 1 |
| Goshima, Y; Hasegawa, M; Hensley, K; Masukawa, D; Nagai, J; Ohshima, T; Togashi, K; Tonouchi, A | 1 |
| Cano, J; Hernández-Romero, MC; Machado, A; Santiago, M | 1 |
| Dodd, CA; Klein, BG | 1 |
| Fujita, K; Katafuchi, T; Kido, MA; Nakabeppu, Y; Noda, M; Ohno, M; Sakumi, K; Seike, T; Takaki, A; Tanaka, Y; Yamada, H; Yamaguchi, H; Yamakawa, Y; Yutsudo, N | 1 |
| Cho, KH; Cho, SH; Hong, J; Ju, MS; Kim, DH; Kim, HG; Kim, SY; Lee, EH; Oh, MS; Park, W | 1 |
| Cho, KH; Doo, AR; Eun-Kyung, K; Hong, J; Jung, JH; Jung, WS; Kim, SN; Lee, H; Moon, SK; Park, HJ; Park, JY | 1 |
| Choi, JG; Huh, Y; Kim, HG; Kim, MC; Kim, SY; Oh, MS; Yang, WM | 1 |
8 other study(ies) available for 4-phenyl-1,2,3,6-tetrahydropyridine and Disease Models, Animal
| Article | Year |
|---|---|
Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Disease Models, Animal; Enteric Nervous System; Gastrointestinal Diseases; Gastrointestinal Microbiome; Inflammation; Male; Mice, Inbred C57BL; Parkinson Disease | 2018 |
Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Intercellular Signaling Peptides and Proteins; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Motor Activity; Neostriatum; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Phosphorylation; Substantia Nigra; Suppression, Genetic | 2019 |
Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Microdialysis; Nerve Endings; Neuroprotective Agents; Parkinson Disease; Perfusion; Rats; Rats, Wistar; Simvastatin | 2009 |
Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatu
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chlorpyrifos; Disease Models, Animal; Drug Combinations; Drug Interactions; Glial Fibrillary Acidic Protein; Insecticides; Mice; Mice, Inbred C57BL; Neostriatum; Neuropil; Parkinsonian Disorders; Permethrin; Tyrosine 3-Monooxygenase | 2009 |
Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Hydrogen; Lipid Peroxidation; Mice; Neurodegenerative Diseases; Neurons; Oxidative Stress; Oxygen; Parkinson Disease; Risk; Water; Water Supply | 2009 |
Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Caspase 3; Cell Death; Cells, Cultured; Disease Models, Animal; Dopamine; Drugs, Chinese Herbal; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Substantia Nigra | 2010 |
Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Caspase 3; Cell Line, Tumor; Chromones; Cytotoxins; Disease Models, Animal; Dopamine; Drugs, Chinese Herbal; Enzyme Inhibitors; Humans; Magnoliopsida; Male; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Neuroblastoma; Neurons; Neuroprotective Agents; Parkinson Disease; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-akt | 2010 |
Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Caspase 3; Cell Death; Disease Models, Animal; Dopamine; Male; Medicine, Korean Traditional; Mice; Mice, Inbred C57BL; Neurons; Nitric Oxide; Oxidopamine; Parkinson Disease; PC12 Cells; Phytotherapy; Plant Extracts; Plant Roots; Polygala; Rats; Reactive Oxygen Species | 2011 |